DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
DRNA
Delisted
DRNA was delisted on the 27th of December, 2021.
48 hedge funds and large institutions have $71.1M invested in Dicerna Pharmaceuticals, Inc. in 2016 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 17 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
53% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 17
Holders
48
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$2.06M | |
| 2 | +$1.53M | |
| 3 | +$1.46M | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$549K |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
+$294K |
Top Sellers
| 1 | -$2.01M | |
| 2 | -$1.88M | |
| 3 | -$1.48M | |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$1.34M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$283K |